The International Research Laboratory established in Ribeirão Preto is the first immunology research facility outside France.
This content is in Portuguese.
This content is in Portuguese.
After approval, the clinical trial will be able to recruit and treat patients with B-cell acute lymphoblastic leukemia or B-cell non-Hodgkin’s lymphoma at partner centers beginning in 2025.
The waiver applies to both current and new members.
This content is in Portuguese.
This content is in Portuguese.
The course will include theoretical and practical content and will host students from South American countries in São Paulo.
This content is in Portuguese.
The event allowed students to interact with experienced researchers and exchange knowledge.
This content is in Portuguese.
This content is in Portuguese.